Clayface Tops US Box Office with $24 Million Opening as DC’s Body-Horror Gamble Pays Off

DC Studios has scored a modest but meaningful win at the North American box office: Clayface, its R-rated body-horror take on the Batman villain, opened at No. 1 with $24 million, according to studio estimates reported by the Associated Press on Sunday. The film added $19 million internationally, giving it a $43 million worldwide debut — a solid start for a film budgeted at only $44 million, a fraction of the cost of most comic-book movies.

The weekend’s bigger sensation, though, was the film in second place. A24’s Elizabeth Holmes documentary You Can See Everything, directed by Nathan Fielder and Lance Oppenheim, pulled in $19.5 million in its first weekend of wide release after expanding from 855 to 2,655 locations, taking its two-week total to $45.1 million — already among the highest-grossing documentaries ever, powered in large part by Gen Z audiences.

Clayface itself is an unusual proposition for a comic-book film. Directed by James Watkins from a screenplay by Mike Flanagan and Hossein Amini, it stars Tom Rhys Harries as Matt Hagen, a Gotham street kid turned Hollywood leading man whose career is destroyed when a crime boss leaves him horribly disfigured. Abandoned by his team, Hagen turns to an experimental treatment that restores his face — but loosens his grip on reality, sending him down a path of all-consuming revenge. Naomi Ackie, David Dencik, Max Minghella, Eddie Marsan, Nancy Carroll and Joshua James co-star, with Matt Reeves, Lynn Harris, James Gunn and Peter Safran producing. The film opened in 3,458 theatres in North America on October 23, with international rollout beginning October 21.

Watch the final trailer here:

Here is the Filmverse take: Clayface’s opening matters less as a number than as a proof of concept. For years, the comic-book movie has meant one thing — a $200 million-plus hero, a universe to service, a four-quadrant audience to please. A $44 million R-rated horror film about a villain, with no hero in sight, succeeding on its own terms suggests a different, cheaper, more interesting future for DC under Gunn and Safran: smaller bets, stranger genres, and characters allowed to be monstrous rather than marketable.

All box-office figures are trade estimates. Sources: Associated Press, Variety